10% Off
Salflu50 mcg+100
ACME Laboratories Ltd.
৳58.50
Add to cart
Generic medicine
Salmeterol + Fluticasone Propionate: Brands, Price & Uses in Bangladesh
Salmeterol + Fluticasone Propionate is a combination inhaled medicine containing a long-acting beta-2 agonist (salmeterol) and an inhaled corticosteroid (fluticasone propionate).
About Salmeterol + Fluticasone Propionate
Indications of Salmeterol + Fluticasone Propionate
Salmeterol + Fluticasone Propionate is a combination inhaled medicine containing a long-acting beta-2 agonist (salmeterol) and an inhaled corticosteroid (fluticasone propionate). It is indicated for the following:
Established / FDA-approved uses
- Asthma (long-term maintenance): Regular twice-daily maintenance treatment of asthma in patients aged 4 years and older who are not adequately controlled on a long-term asthma-control medication (such as an inhaled corticosteroid alone), or whose disease severity clearly warrants initiation of treatment with both an inhaled corticosteroid and a long-acting beta-2 agonist (LABA).
- Chronic obstructive pulmonary disease (COPD): Long-term, twice-daily maintenance treatment of airflow obstruction and reduction of exacerbations in patients with COPD, including chronic bronchitis and/or emphysema.
Important limitations
- Salmeterol + Fluticasone Propionate is not a rescue inhaler and must not be used to relieve acute bronchospasm or an acute asthma/COPD exacerbation; a short-acting bronchodilator should be used for acute symptoms.
- It is not indicated as the first medicine for treating asthma; it is used as combination maintenance therapy once an inhaled corticosteroid alone is judged insufficient, or when combination therapy is otherwise appropriate.
Dosage & Administration of Salmeterol + Fluticasone Propionate
The dose of Salmeterol + Fluticasone Propionate is individualized by a physician based on the patient's age, diagnosis (asthma vs COPD), and disease severity. It must be taken exactly as prescribed, twice daily approximately 12 hours apart, and is not for relief of acute symptoms.
| Indication | Population | Typical Dosing |
|---|---|---|
| Asthma maintenance | Adults and adolescents (12 years and older) | One inhalation twice daily; strength (lowest effective dose of the corticosteroid component) selected by the physician based on asthma severity and prior therapy. |
| Asthma maintenance | Children 4 to 11 years | One inhalation of the lowest-strength combination twice daily, as prescribed; higher strengths are generally not used in this age group. |
| COPD maintenance | Adults | One inhalation of the strength containing the higher fluticasone propionate dose (as specifically approved for COPD), twice daily. |
See Dosage and Administration sections below for further detail, and Use in Special Populations for renal/hepatic considerations.
Side Effects of Salmeterol + Fluticasone Propionate
Side effects of Salmeterol + Fluticasone Propionate vary by indication and may include:
Common side effects
- Upper respiratory tract infection, throat irritation/pharyngitis
- Oral thrush (candidiasis) and hoarseness/dysphonia — reduced by rinsing the mouth after use
- Headache
- Nausea, vomiting
- Musculoskeletal pain, muscle cramps
- Increased incidence of pneumonia has been observed in COPD patients using inhaled corticosteroid-containing products
Less common but important effects
- Paradoxical bronchospasm (immediate worsening of wheezing after a dose) — discontinue and seek urgent medical review if this occurs.
- Tremor, palpitations, tachycardia (from the LABA component)
- Signs of systemic corticosteroid effect with prolonged/high-dose use (see Precautions and Warnings).
- Hypersensitivity reactions, including rash, urticaria, and rarely angioedema or anaphylaxis.
Contraindications of Salmeterol + Fluticasone Propionate
Salmeterol + Fluticasone Propionate is contraindicated in:
- Patients with known hypersensitivity to salmeterol, fluticasone propionate, or any excipient of the specific product (including, for dry powder formulations that use a lactose carrier, patients with severe hypersensitivity to milk proteins).
- As the primary treatment of status asthmaticus or other acute episodes of asthma or COPD requiring intensive measures — it is not a rescue medicine.
Frequently Asked Questions about Salmeterol + Fluticasone Propionate
What is Salmeterol + Fluticasone Propionate used for?
Salmeterol + Fluticasone Propionate is a combination inhaler used for the long-term, twice-daily maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It combines a long-acting bronchodilator with an anti-inflammatory corticosteroid to keep airways open and reduce inflammation over time. It is not for relieving a sudden asthma attack or acute breathing difficulty.
Can I use Salmeterol + Fluticasone Propionate for a sudden asthma attack?
No. Salmeterol + Fluticasone Propionate is not a rescue medicine and does not act quickly enough to relieve sudden bronchospasm or an acute asthma/COPD attack. A separate fast-acting (short-acting) bronchodilator inhaler should be used for sudden symptoms, and patients should always carry that rescue inhaler as advised by their physician.
Why do I need to rinse my mouth after using this inhaler?
Rinsing the mouth with water and spitting it out after each dose of Salmeterol + Fluticasone Propionate helps remove residual corticosteroid left in the mouth and throat, which significantly reduces the risk of oral thrush (candidiasis) and hoarseness (dysphonia), both recognized side effects of the inhaled corticosteroid component.
Is Salmeterol + Fluticasone Propionate safe during pregnancy?
Salmeterol + Fluticasone Propionate should be used in pregnancy only if clearly needed, since data on its use in pregnant women are limited. However, poorly controlled asthma or COPD can itself harm both mother and baby, so most physicians continue treatment when it is genuinely required. Pregnant women should not start or stop this medicine without consulting their physician first.
What are the serious risks I should know about?
Long-acting beta-2 agonists such as the salmeterol component in Salmeterol + Fluticasone Propionate carry a boxed warning for an increased risk of asthma-related death when used alone without an inhaled corticosteroid; this product combines both, which reduces but does not remove that class-wide concern. Other important risks include paradoxical bronchospasm (sudden worsening of wheezing after a dose, requiring immediate discontinuation), increased risk of pneumonia in COPD patients, and, with long-term or high-dose use, systemic corticosteroid effects such as adrenal suppression, slowed growth in children, and reduced bone density.
Can children use Salmeterol + Fluticasone Propionate?
Salmeterol + Fluticasone Propionate may be used in children aged 4 years and older, using the lowest available strength, strictly as prescribed by a physician for asthma maintenance. Its safety and efficacy have not been established in children under 4 years, and it is not used for COPD in children, since COPD does not occur in this age group.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.